1. Long‐Term Follow‐Up of Patients With Positive Antiphospholipid Antibodies After Fetal Death: Five Typical Cases From a Prospective Cohort Study
- Author
-
Anxia Xie, Zhanmei Liu, Shenglan Wang, Mingqian Yuan, Ling Xie, Shengdong Liu, and Xiaoxing Wei
- Subjects
antiphospholipid antibody ,case report ,fetal death ,subsequent pregnancy ,thrombosis ,Immunologic diseases. Allergy ,RC581-607 - Abstract
ABSTRACT Background Testing of antiphospholipid antibodies (aPLs) has attracted increasing attention for its association with thrombosis and pregnancy loss. However, few studies reported long‐term monitoring outcomes of patients who experienced pregnancy loss and exhibited positivity for aPLs. Objective We investigated the causes of fetal death in five cases with positive aPLs and traced the patients for changes in aPLs, subsequent pregnancy outcomes, and thrombotic events. Methods This is a report of five typical cases from a prospective cohort study on the diagnosis of antiphospholipid syndrome (APS) in patients who were hospitalized for fetal death in Xining, China. Long‐term follow‐up was conducted and repeat aPL testing was recommended when the patients were confirmed or suspect APS. Results All five patients had subsequent pregnancies that resulted in term livebirths. None of the patients experienced thrombotic events. One showed progression of aPL serostatus from alone IgM of aβ2GP‐1 to both IgM and IgG of aβ2GP‐1, two exhibited fluctuation of aPL serostatus, and one had negative conversion, and the other one had not retested aPLs and did not receive any intervention with uneventful subsequent pregnancy. Conclusions The aPLs of a patient with APS may develop or may disappear, so long‐term monitoring cannot be discounted. Also, a woman who has experienced fetal death and exhibits positivity for aPLs may not necessarily be a patient with APS, as there are a variety of conditions in which aPLs appear.
- Published
- 2025
- Full Text
- View/download PDF